Enhance Care
with Genetic Insignts
with Genetic Insignts
We’re dedicated to helping people live their best days by helping them better understand their genome with GENETICSNOW®
Guidance
Doctor/Patient Support
Family planning
Useful for future family planning
Early Intervention
Early Diagnosis
Bringing solutions to genetic testing.
GoPath's GeneticsNow® Series includes a collection of next-generation sequencing panels that detect germline variants associated with an increased risk for various hereditary cancers. Our germline tests are clinical grade, with fast turnaround times and actionable results. We also have in-house contracted genetic counselors to aid in the interpretation of results and to provide guidance to patients.
This COMPREHENSIVE GERMLINE PANEL analyzes 88 clinically-relevant genes that are associated with genetic disorders, including most hereditary cancers.
PROSTATENOW is a germline test for people with prostate cancer. This test can be used to predict prognosis among men with localized prostate cancer, predict therapeutic responses for advanced patients, and predict cancer risk among unaffected men.
BRCANOW is a next-generation sequencing panel for people with a personal or family history of breast or ovarian cancer.
LYNCHNOW is a cost-effective, screening tool that rapidly detects mutations that cause Lynch syndrome.
DIABETESNOW is a unique genetic panel that tests for 16 genes associated with MODY, syndromic, neonatal, and mitochondrial causes of monogenic diabetes. It also includes pan-ancestry type 1 and 2 diabetes polygenic risk scores (PRS) and the probability of type 1 diabetes (GenProb-T1D).
Our foundation is innovation.
We employ the best team, utilize the latest molecular technology and techniques, and build collaborations with key innovation partners.
